Werewolf Therapeutics, Inc. (HOWL) Misses Q1 EPS by 2c

Werewolf Therapeutics, Inc. (NASDAQ: HOWL) reported Q1 EPS of ($0.40), $0.02 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Werewolf Therapeutics, Inc. (HOWL) click here.

You May Also Be Interested In

• McEwen Copper seeks $1.6b in equity financing for Los Azules - Bloomberg
• 374Water Inc (SCWO) Misses Q2 EPS by 15c
• Klarna shares tumble on weak full-year revenue guidance